VAUGHAN, Ontario — Bausch + Lomb Corp. announced the U.S. launch of PreserVision AREDS3 eye vitamins, which combine the clinically proven AREDS2 nutrients recommended by the NEI to help reduce the risk of moderate-to-advanced AMD progression with a unique B-vitamin complex. Built on decades of leadership in AREDS-based vitamins, PreserVision AREDS3 is the most advanced PreserVision formula, intended to support a broader range of people, including those in earlier stages.
For decades, nutritional support for AMD has been centered on stage-specific intervention, with clinically proven AREDS2 nutrients serving as a way to help reduce the risk of progression in people with moderate-to-advanced AMD. PreserVision AREDS3 eye vitamins build on that scientific foundation by incorporating a proprietary B-vitamin complex informed by decades of research, enabling eye care professionals to initiate nutritional support earlier and engage a broader population.
“AMD affects millions of people, often long before symptoms meaningfully change day-to-day life,” said John Ferris, president, Consumer, Bausch + Lomb. “Historically, options to support macular health earlier in the condition have been limited. PreserVision AREDS3 reflects decades of research, and our commitment to advancing eye health through science, offering an option for a broader range of people looking to support their macular health.”
AMD is the leading cause of vision loss among older Americans, impacting approximately 28 million people in the U.S. This progressive condition can impact central vision in one or both eyes, causing people to have difficulty with daily activities like driving, reading or recognizing the faces of loved ones.
PreserVision AREDS3 eye vitamins build on the trusted AREDS2 nutrients by adding a research-backed, unique B-vitamin complex. The formula is designed to provide triple-action support:
- Protects: AREDS2 nutrients help protect macular health by neutralizing free radicals and replenishing the eyes’ natural filter
- Nourishes: Unique B‑vitamin complex, containing thiamin (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), vitamin B6, biotin (B7), folate (B9) and vitamin B12, which was designed to promote healthy cellular eye function*
- Boosts: Formulated to provide two times better absorption of key nutrients
“Nutritional support for AMD management has to evolve as the science evolves,” said Julie Poteet, OD, MS, CNS. “PreserVision AREDS3 eye vitamins reflect the most current thinking in nutritional support for macular health, building on the established AREDS2 nutrients and incorporating a unique B-vitamin complex backed by more than two decades of scientific research on B vitamins.2 That matters in practice, because it gives me greater confidence and flexibility when discussing nutritional options with a broader group of patients, including those in earlier stages.”
The development of PreserVision AREDS3 was guided by a growing body of scientific evidence examining the role of certain B vitamins in AMD, including certain studies described in a recently published narrative review in Ophthalmology and Therapy.2 The review drew on more than two decades of human research, synthesizing findings from more than 20 human studies involving nearly 30,000 individuals, including large randomized clinical trials such as the Women’s Antioxidant and Folic Acid Cardiovascular Study, which reported a statistically significant association between specific B‑vitamin supplementation and reduced AMD risk. This body of evidence helped shape the inclusion of B vitamins in PreserVision AREDS3 eye vitamins and supports ongoing research in this area, including plans for a future long‑term clinical trial evaluating the formulation.
PreserVision AREDS3 eye vitamins are now available in the eye care aisle or online at most retailers nationwide, including Amazon, Target, Walgreens and Walmart. For more information, visit www.preservision.com.
